United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2018

Name: United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2018
Brand: QYResearch
SKU: U77D4D5C926QEN
Price: 3800 USD
Availability: InStock

March 2018 | 104 pages | ID: U77D4D5C926QEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer

Checkout Later

Need Help? Ask a Question

In this report, the United States Chemotherapy-Induced Nausea and Vomiting Drugs market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Chemotherapy-Induced Nausea and Vomiting Drugs in these regions, from 2013 to 2025 (forecast).

United States Chemotherapy-Induced Nausea and Vomiting Drugs market competition by top manufacturers/players, with Chemotherapy-Induced Nausea and Vomiting Drugs sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Merck & Co., Inc.
GlaxoSmithKline plc
Tesaro, Inc.
Helsinn Group
F. Hoffmann-La Roche Ltd.
Heron Therapeutics, Inc.
Dr. Reddy's Laboratories Ltd.
Acacia Pharma
Sun Pharmaceutical Industry Ltd.
Otsuka Holdings Co., Ltd.

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Existing Drugs
Akynzeo (Netupitant-Palonosetron FDC)
Aloxi (Palonosetron)
Emend (Aprepitant)
Kytril Generic (Granisetron)
Zofran Generic (Ondansetron)
Pipeline Drugs
SUSTOL (Granisetron Injection extended release)
Rolapitant

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

Serotonin Receptor Antagonists
NK1 Receptor Antagonists

If you have any special requirements, please let us know and we will offer you the report as you want.

United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2018

1 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS OVERVIEW

1.1 Product Overview and Scope of Chemotherapy-Induced Nausea and Vomiting Drugs
1.2 Classification of Chemotherapy-Induced Nausea and Vomiting Drugs by Product Category
  1.2.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Sales Volume) Comparison by Type (2013-2025)
  1.2.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Sales Volume) Market Share by Type (Product Category) in 2017
  1.2.3 Existing Drugs
  1.2.4 Akynzeo (Netupitant-Palonosetron FDC)
  1.2.5 Aloxi (Palonosetron)
  1.2.6 Emend (Aprepitant)
  1.2.7 Kytril Generic (Granisetron)
  1.2.8 Zofran Generic (Ondansetron)
  1.2.9 Pipeline Drugs
  1.2.10 SUSTOL (Granisetron Injection extended release)
  1.2.11 Rolapitant
1.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market by Application/End Users
  1.3.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Consumption) and Market Share Comparison by Application (2013-2025)
  1.3.2 Serotonin Receptor Antagonists
  1.3.3 NK1 Receptor Antagonists
1.4 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market by Region
  1.4.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 The West Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
  1.4.3 Southwest Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
  1.4.4 The Middle Atlantic Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
  1.4.5 New England Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
  1.4.6 The South Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
  1.4.7 The Midwest Chemotherapy-Induced Nausea and Vomiting Drugs Status and Prospect (2013-2025)
1.5 United States Market Size (Value and Volume) of Chemotherapy-Induced Nausea and Vomiting Drugs (2013-2025)
  1.5.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Growth Rate (2013-2025)
  1.5.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Growth Rate (2013-2025)

2 UNITED STATES CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share of Key Players/Suppliers (2013-2018)
2.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Share by Players/Suppliers (2013-2018)
2.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Average Price by Players/Suppliers (2013-2018)
2.4 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Competitive Situation and Trends
  2.4.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Concentration Rate
  2.4.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2013-2018)

3.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Region (2013-2018)
3.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Market Share by Region (2013-2018)
3.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Price by Region (2013-2018)

4 UNITED STATES CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2013-2018)

4.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Type (Product Category) (2013-2018)
4.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue and Market Share by Type (2013-2018)
4.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Price by Type (2013-2018)
4.4 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Type (2013-2018)

5 UNITED STATES CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS SALES (VOLUME) BY APPLICATION (2013-2018)

5.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales and Market Share by Application (2013-2018)
5.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Application (2013-2018)
5.3 Market Drivers and Opportunities

6 UNITED STATES CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Merck & Co., Inc.
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.1.4 Main Business/Business Overview
6.2 GlaxoSmithKline plc
  6.2.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.2.4 Main Business/Business Overview
6.3 Tesaro, Inc.
  6.3.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.3.4 Main Business/Business Overview
6.4 Helsinn Group
  6.4.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.4.4 Main Business/Business Overview
6.5 F. Hoffmann-La Roche Ltd.
  6.5.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.5.4 Main Business/Business Overview
6.6 Heron Therapeutics, Inc.
  6.6.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.6.4 Main Business/Business Overview
6.7 Dr. Reddy's Laboratories Ltd.
  6.7.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.7.4 Main Business/Business Overview
6.8 Acacia Pharma
  6.8.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.8.4 Main Business/Business Overview
6.9 Sun Pharmaceutical Industry Ltd.
  6.9.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.9.4 Main Business/Business Overview
6.10 Otsuka Holdings Co., Ltd.
  6.10.2 Chemotherapy-Induced Nausea and Vomiting Drugs Product Category, Application and Specification
    6.10.2.1 Product A
    6.10.2.2 Product B
  6.10.3 Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales, Revenue, Price and Gross Margin (2013-2018)
  6.10.4 Main Business/Business Overview

7 CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MANUFACTURING COST ANALYSIS

7.1 Chemotherapy-Induced Nausea and Vomiting Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Chemotherapy-Induced Nausea and Vomiting Drugs Major Manufacturers in 2017
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CHEMOTHERAPY-INDUCED NAUSEA AND VOMITING DRUGS MARKET SIZE (VALUE AND VOLUME) FORECAST (2018-2025)

11.1 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume, Revenue Forecast (2018-2025)
11.2 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Forecast by Type (2018-2025)
11.3 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Forecast by Application (2018-2025)
11.4 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Forecast by Region (2018-2025)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

LIST OF TABLES AND FIGURES

Figure Product Picture of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (K Units) by Type (2013-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Market Share by Type (Product Category) in 2017
Figure Existing Drugs Product Picture
Figure Akynzeo (Netupitant-Palonosetron FDC) Product Picture
Figure Aloxi (Palonosetron) Product Picture
Figure Emend (Aprepitant) Product Picture
Figure Kytril Generic (Granisetron) Product Picture
Figure Zofran Generic (Ondansetron) Product Picture
Figure Pipeline Drugs Product Picture
Figure SUSTOL (Granisetron Injection extended release) Product Picture
Figure Rolapitant Product Picture
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (K Units) by Application (2013-2025)
Figure United States Sales Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Application in 2017
Figure Serotonin Receptor Antagonists Examples
Table Key Downstream Customer in Serotonin Receptor Antagonists
Figure NK1 Receptor Antagonists Examples
Table Key Downstream Customer in NK1 Receptor Antagonists
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Size (Million USD) by Region (2013-2025)
Figure The West Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southwest Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Middle Atlantic Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure New England Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The South of US Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure The Midwest Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) and Growth Rate (2013-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate (2013-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Major Players Product Sales Volume (K Units) (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) of Key Players/Suppliers (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players/Suppliers (2013-2018)
Figure 2017 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players/Suppliers
Figure 2017 United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Players/Suppliers
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Major Players Product Revenue (Million USD) (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) by Players/Suppliers (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players/Suppliers (2013-2018)
Figure 2017 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players/Suppliers
Figure 2017 United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Players/Suppliers
Table United States Market Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Players/Suppliers (2013-2018)
Figure United States Market Chemotherapy-Induced Nausea and Vomiting Drugs Average Price (USD/Unit) of Key Players/Suppliers in 2017
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Share of Top 3 Players/Suppliers
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Chemotherapy-Induced Nausea and Vomiting Drugs Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Chemotherapy-Induced Nausea and Vomiting Drugs Product Category
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Region (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Region (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Region (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Region in 2017
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Region (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Region (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share by Region in 2017
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Region (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Type (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Share by Type (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Type in 2017
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Market Share by Type (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type (2013-2018)
Figure Revenue Market Share of Chemotherapy-Induced Nausea and Vomiting Drugs by Type in 2017
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) by Types (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Type (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units) by Application (2013-2018)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share by Application in 2017
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Application (2013-2018)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate by Application (2013-2018)
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure Merck & Co., Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table GlaxoSmithKline plc Basic Information List
Table GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure GlaxoSmithKline plc Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table Tesaro, Inc. Basic Information List
Table Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure Tesaro, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table Helsinn Group Basic Information List
Table Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure Helsinn Group Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table F. Hoffmann-La Roche Ltd. Basic Information List
Table F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure F. Hoffmann-La Roche Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table Heron Therapeutics, Inc. Basic Information List
Table Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure Heron Therapeutics, Inc. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table Dr. Reddy's Laboratories Ltd. Basic Information List
Table Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure Dr. Reddy's Laboratories Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table Acacia Pharma Basic Information List
Table Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure Acacia Pharma Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table Sun Pharmaceutical Industry Ltd. Basic Information List
Table Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure Sun Pharmaceutical Industry Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table Otsuka Holdings Co., Ltd. Basic Information List
Table Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2013-2018)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Growth Rate (2013-2018)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Sales Market Share in United States (2013-2018)
Figure Otsuka Holdings Co., Ltd. Chemotherapy-Induced Nausea and Vomiting Drugs Revenue Market Share in United States (2013-2018)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Manufacturing Process Analysis of Chemotherapy-Induced Nausea and Vomiting Drugs
Figure Chemotherapy-Induced Nausea and Vomiting Drugs Industrial Chain Analysis
Table Raw Materials Sources of Chemotherapy-Induced Nausea and Vomiting Drugs Major Players/Suppliers in 2017
Table Major Buyers of Chemotherapy-Induced Nausea and Vomiting Drugs
Table Distributors/Traders List
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) and Growth Rate Forecast (2018-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Price (USD/Unit) Trend Forecast (2018-2025)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Type (2018-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Type in 2025
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Application (2018-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Application in 2025
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume (K Units) Forecast by Region (2018-2025)
Table United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share Forecast by Region (2018-2025)
Figure United States Chemotherapy-Induced Nausea and Vomiting Drugs Sales Volume Share Forecast by Region in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

United States Chemotherapy-Induced Nausea and Vomiting Drugs Market Report 2018

More Publications

Need Help?

Ask a Question

Market Reports